samedan logo

 
 
spacer
home > ict > summer 2019 > plan, track, and refine
PUBLICATIONS
International Clinical Trials

Plan, Track, and Refine




‘Eating healthy is easy’. This is a sentiment you are unlikely to hear from someone who is trying to change their eating habits. For most people, eating healthy requires a plan, the discipline, and the willingness to adapt to changing circumstances. Put simply, a great deal of thought and effort are required to see real and consistent results. Similarly, ‘managing enrolment is easy’ is not something you are likely to hear from a sponsor who has had issues in the past or is heading into a new therapeutic area. Much like eating healthy, enrolment requires sponsors and CROs to develop, track, and continually refine a plan to hit their targets and ensure the health of their trial.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
About the author


Mark Springer has over 20 years of clinical operations expertise, with a focus on trial and project management and recruitment and retention enhancements, as well as driving the adoption of new innovation through change management. Within the Consultative Services group, Mark is the lead Subject Matter Expert for the trial optimiser services, which includes StudyOptimizer. Together, these are tools that help study teams plan, track, diagnose, and optimise patient enrolment.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

What Your Clinical Study Design Reveals About Your Clinical Packaging Needs

PCI Pharma Services

As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >>

 
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement